Overview

Safety and Efficacy of Twelve Hours Duration of MgSO4 in the Treatment of Eclampsia in Low Resource Setting in Sudan

Status:
Unknown status

Trial end date:
2019-06-30

Target enrollment:

Participant gender:

Summary

the investigators assume that magnesium sulphate for treating eclampsia can be safely reduced from 24 hours to shorter duration of therapeutic anticonvulsant effect for 12 hours. Short duration of drug exposure is suitable for low resource setting where there is little tools or busy staff for monitoring drug toxicity.

Phase:

N/A

Details

Lead Sponsor:

Gadarif University

Treatments:

Magnesium Sulfate